Glover E, Abrahamson A, Adams J, Poken S R, Hainsworth S-L, Lamprecht A, Delport T, Keulder T, Olivier T, Maasdorp S D
Division of Infectious Diseases, Department of Internal Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Medical students, Department of Internal Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Afr J Thorac Crit Care Med. 2022 May 5;28(1). doi: 10.7196/AJTCCM.2022.v28i1.175. eCollection 2022.
Central line-associated bloodstream infections (CLABSIs) are frequently encountered device-related healthcare-associated infections in critically ill patients, causing substantial morbidity, mortality and prolonged hospitalisation.
To determine the incidence of CLABSI, median catheter dwell-time prior to developing CLABSI, as well as the causative microorganisms of CLABSI among patients admitted to the multidisciplinary intensive care unit (MICU) at Universitas Academic Hospital, Bloemfontein.
We conducted a retrospective review of medical and laboratory records of all MICU patients who had a central line placed between January and December 2018.
A total of 377 patients were admitted to the MICU in 2018, of which 182 met the inclusion criteria for the present study. From the cohort of 182 patients, 16.5% (n=30) of patients presented with 32 CLABSI episodes, with two patients having had two independent episodes each. A total of 1 215 central line days were recorded, yielding a CLABSI rate of 26.3/1 000-line days. Laboratory analysis identified microorganisms in 38 blood cultures, with Gram-negative organisms (55.3%; n=21) being predominant over Gram-positive organisms (39.5%; n=15) and fungi (5.3%; n=2).
The incidence of CLABSI at the MICU at Universitas Academic Hospital is high. Urgent intervention with strict compliance to prevention bundles is required to reduce the high incidence of CLABSI.
中心静脉导管相关血流感染(CLABSI)是重症患者中常见的与器械相关的医疗保健相关感染,会导致严重的发病、死亡和住院时间延长。
确定位于布隆方丹大学学术医院多学科重症监护病房(MICU)的患者中CLABSI的发生率、发生CLABSI之前中心静脉导管的中位留置时间,以及CLABSI的致病微生物。
我们对2018年1月至12月期间所有在MICU放置中心静脉导管的患者的医疗和实验室记录进行了回顾性研究。
2018年共有377名患者入住MICU,其中182名符合本研究的纳入标准。在这182名患者队列中,16.5%(n = 30)的患者出现了32次CLABSI发作,其中两名患者各自有两次独立发作。总共记录了1215个中心静脉导管日,CLABSI发生率为26.3/1000导管日。实验室分析在38份血培养物中鉴定出微生物,革兰氏阴性菌(55.3%;n = 21)比革兰氏阳性菌(39.5%;n = 15)和真菌(5.3%;n = 2)更占优势。
大学学术医院MICU的CLABSI发生率很高。需要严格遵守预防措施进行紧急干预,以降低CLABSI的高发生率。